Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Bro I have an 8 figure trading account too late for that! Wish I had gambled 610,000 shares instead!
you will get rich soonnnnn
In with 61K shares acb 94 cents! All sells in the $5-15 range here this year! Just need that FDA to drop and Mama’s Happy! 👏🏻😜
yup if the ceo mother buy shares we should be good here
Binary play here! You either make 1000% or lose 80%! Your choice! This won’t be $2 in 60-90 days,
Would it be wise to procure shares at this point?
You always talk to yourself bro?
Dude you called it, ssshhh quiet, we are rising up slowly. Explosion coming
Market Cap
22M
Shares in Issue
11.70M
You listening to the call? The link didn’t work for Zoom! 😡
idiot im here from 0.8s and still holding
Check your pants shortie! 💩
Check your pants shortie! 💩
Inspira™ Announces Breakthrough Update: Nears First FDA 510(k) Approval, 3 U.S. Patents Approved, $546 million in Summary Distribution Agreements
https://finance.yahoo.com/news/inspira-announces-breakthrough-nears-first-120000598.html
Inspira™ Announces Breakthrough Update: Nears First FDA 510(k) Approval, 3 U.S. Patents Approved, $546 million in Summary Distribution Agreements
https://finance.yahoo.com/news/inspira-announces-breakthrough-nears-first-120000598.html
yup but i smell a offering coming
Moving up slowly, but one of these days it's going to boom. Only 11.7 M shares outstanding
yep, boom .03 penny jump is just the start,bring on the nickles and dimes
accumulation at open .0005 now .20,thats astounding buying and holding!! MMX just moved up to 1.26,lets see what happens if he stays there
bad mm,"MMX"@1.24,thru it and should move up fast to where ever MMX moves up to,hopefully $2 ,bid(demand) growing now so it shouldn't be long,MMX@ bid 1.19 support also
finally the bounce off sma50(5min) i had bids in for filled 1.17/1.18 support
23%/12% volatility,eps surprise of 27%6.4m cash(offering dec 28),flipped to bullish 2 days ago,sma200@ 1.27 (blue sky ma res. above) awaiting fda approvals is why it started going up,ppl at fda/insiders/tutes know what is coming,$100's of millions rev. is fueling greed here!
nhod's,med patent approval,tutes transactions up 67%,zb and not optionable,gone up all day (didnt even flinch in death hour)
geez my nose almost gone
You tell me????? Do your own DD.
Look for the 13-F's. Why----Inspira is working on establish collaborations with strategic partners and globally ranked health centers, to provide endorsement and future clinical adoption of its ART system. In addition, Inspira explores collaborations with leading medical device companies, manufactures, and distributors. The development of a strategic team is key to enable Inspira to rapidly deploy the ART in the future.
were is the clinical proof ????
Interview with Dagi Ben-Noon, Co-Founder and CEO at Inspira Technologies (Nasdaq: IINN):
Web Link to Interview
I think this is huge as the best option to avoid the Ventilator, which will most likely kill you! Just my thoughts.
Q: Could you provide our readers with a brief introduction to your company?
A: Inspira Technologies is an innovative medical technology company in the respiratory treatment arena. Inspira has a vision- Provide a new innovative way to treat respiratory failure. Every year approx. 20 million patients are admitted to ICUs due to respiratory failure, being intubated, placed in a medically induced coma, and undergo mechanical ventilation. Inspira’s ART system designed to prevent the need for mechanical ventilation (MV), whose disadvantages have become more apparent since the beginning of the COVID-19 pandemic. Inspira develops a cost-effective minimally invasive Extracorporeal Respiratory Support (ECRS) technology, which the company believes has the potential to utilize oxygen to rebalance patients’ saturation levels while they are awake.
Inspira’s ART system, which is based on ECRS technology, acts as external lungs, by withdrawing blood through a dual lumen cannula inserted into the jugular vein, enriching it with a high concentration of oxygen, removing CO2, and returning the enriched blood to rebalance patient’s saturation levels and take the load off the lungs. Inspira’s technology has the potential to prevent the need for mechanical ventilation.
Q: Any highlights on your recent announcement?
A: Inspira completed NASDAQ IPO last month, since than the company appointed a new medical board member to its advisory board, Dr. Dekel Stavi which considerable experience in Extracorporeal Life Support programs, and cardiology aspects of ICU’s patients, and we believe his experience will contribute Inspira in the next development stages. Inspira also announced the introduction of an innovative microbubble platform designed to extend the life of oxygenators products and potentially prevent blood clots when integrated into a treatment regimen.
Q: Can you give us more insights into your offering?
A: Inspira Technologies is now listed on the Nasdaq stock exchange under the ticker symbol “IINN”. The IPO was priced on July 13, 2021, with the official closing scheduled for Friday, July 16, 2021. The gross proceeds of the offering were approximately $16 million before deducting underwriting discounts, commissions, and offering expenses.
Q: What can we expect from your company in the next 6 months? What are your plans?
A: Inspira taking a multi-step approach to bring its ART system to the market. By the end of 2023, Inspira is planning on introduce the ART system to the market with the new intent of use. As we have two parallel paths that are linked, we will initially submit a 510k to one of our components at the end of 2022, and we plan to submit Inspira’s integrated system 510k at the end of that year. As part of Inspira’s strategy to reach this goal, and in parallel to pursuing regulatory approvals, Inspira is working on establish collaborations with strategic partners and globally ranked health centers, to provide endorsement and future clinical adoption of its ART system. In addition, Inspira explores collaborations with leading medical device companies, manufactures, and distributors. The development of a strategic team is key to enable Inspira to rapidly deploy the ART in the future.
Q: What is the best thing about your company that people might not know about?
A: Passionate and professional team with an innovative vision and a track record of success in execution. A highly experienced management team with a proven track record of success. The chairman, Prof. Benad Goldwasser has 10 exits to his name, Dagi Ben-Noon, one of the Co-Founders, is a serial entrepreneur and was one of Nano Dimension (NNDM) Co-Founders. Joe Hayon, the second Co-Founders and the company’s CFO has extensive experience in executing M&As and strategic joint ventures, manufacturing, and operations to support high-growth delivery. The third Co-Founder is Dr. Udi Nussinovitch is the Chief Scientific Officer of the company. Udi is a board-certified Cardiologist, ICU Physician, and Cardiology Researcher, as well as an expert hyperbaric and diving physician.
Who else sold and bought back today? Netted a bonus 97,000 free shares I didn’t have this morning! See you all at $20 in 2025! I am in Grand Cayman! Probably a good place for next years newly minted millionaire party! 🎉👏🏻
If anyone wondering why company’s stock is surging now
Inspira Receives First Ever U.S. Patent Approval for an Orbiting Blood Oxygenation Delivery System
https://finance.yahoo.com/news/inspira-receives-first-ever-u-123000406.html
They have pending FDA approval, and with the patent approval, it's even more promising. This stock, for me, is strictly for trading purposes, so I won't delve into deep details. Look like the volume has increased, and hopefully, the short sellers will close their positions before the market closes. If they release their grip, this could potentially push the stock back above the $1.60 mark by the close.
Good luck to you bro.
IINN: HOPE you are right, Dude. (Little push-UP in price goin' on right now.)
IINN: Late little run-up here, HOPEFULLY!!
IINN: But at least you scored some nice BANK; & all your points are well taken. (I hate to say this again, but that word "ISRAEL" does NOT help ANY stock these days, in light of the SLAUGHTER they are doing over there. And I ain't no "ANTI-SEMITE" nonsense.)
Most trading happened in pre hours and volume has gone down during the day. Lots of algo-trading as well.
But may seem like volume is picking up again right now. This may in fact trade well after hour and tomorrow, as it's not just a P&D (this mornings action sure looks like one), but the upwards move actually has a reason.
Time will tell if it we end at 1 or 2 tomorrow.
I purchased IINN 1.23 PM and sold it at 1.97. After checking the filings, I found they only had a 5 million offering, which occurred in Oct, last year. Therefore, I decided to reload again, acquiring 3600 shares at 1.17. It's practically impossible to trade with three times the outstanding shares and no movement whatsoever. This situation is criminal, the system needs to address and fix it.
02/14/24 09:02 AM ET Sell 2400 IINN Executed @ $1.9703
IINN: Indeed SICK, P-B!!! (But then --- similar to Pharm PR's about mere PRE-Phase-1 drug studies --- peeps may see this as just a garden-variety PATENT routine, with no substance GADETS for years to come; anyway, that's my guess here. I myself got WAY TOO EXCITED behind this kind of "news".)
Maybe near the Close today, I'll recoup SOME of my loses here.
Pure manipulation. Unless they turn off their robots, this won't do any good. With an outstanding share count of 11.3 million, it's pathetic that we're not moving higher.
How much I wrote about her here, only God knows. Finally the announcement we've been waiting for!!!
Where.
Where is the guy who keeps trying to get us off her?!?
Followers
|
9
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
184
|
Created
|
08/10/21
|
Type
|
Free
|
Moderators |
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |